摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

R,R-N-(1-phenylethyl)-N-1-acetyl-4-(2-chloro-4-fluorophenyl)-2-(2,4,6-trifluorophenyl)-6-methyl-1,4-dihydro-pyrimidin-5-carboxamide | 1005460-01-4

中文名称
——
中文别名
——
英文名称
R,R-N-(1-phenylethyl)-N-1-acetyl-4-(2-chloro-4-fluorophenyl)-2-(2,4,6-trifluorophenyl)-6-methyl-1,4-dihydro-pyrimidin-5-carboxamide
英文别名
(4R)-1-acetyl-4-(2-chloro-4-fluorophenyl)-6-methyl-N-[(1R)-1-phenylethyl]-2-(2,4,6-trifluorophenyl)-4H-pyrimidine-5-carboxamide
R,R-N-(1-phenylethyl)-N-1-acetyl-4-(2-chloro-4-fluorophenyl)-2-(2,4,6-trifluorophenyl)-6-methyl-1,4-dihydro-pyrimidin-5-carboxamide化学式
CAS
1005460-01-4
化学式
C28H22ClF4N3O2
mdl
——
分子量
543.948
InChiKey
LJMAZMQFXKNQEH-PTFIGZPYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    38
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    61.8
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases
    申请人:Li Song
    公开号:US20100087448A1
    公开(公告)日:2010-04-08
    The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof, to a process for preparing the compound of formula (I), and to use of the compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof as a medicament, in particular as a medicament for the treatment and prevention of type B hepatitis.
    本发明涉及一种式(I)的化合物或其药学上可接受的盐或合物,制备该式(I)化合物的方法,以及将该式(I)的化合物或其药学上可接受的盐或合物用作药物,特别是用作治疗和预防乙型肝炎的药物。
  • Optically Pure Dihydropyrimidine Compounds and Their Uses for the Preparation of a Medicament for Treatment and Prevention of Viral Diseases
    申请人:Li Song
    公开号:US20100004268A1
    公开(公告)日:2010-01-07
    The present invention relates to an optically pure compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof, a process for preparing the optically pure compound of formula (I), and use of the optically pure compound of formula (I) or a pharmaceutically acceptable salt or hydrate thereof as a medicament, in particular as a medicament for the treatment and prevention of type B hepatitis.
    本发明涉及公式(I)的光学纯化合物或其药学上可接受的盐或合物,制备公式(I)的光学纯化合物的方法,以及将公式(I)的光学纯化合物或其药学上可接受的盐或合物用作药物,特别是用作治疗和预防B型肝炎的药物。
  • OPTICALLY PURE DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USES FOR THE PREPARATION OF A MEDICAMENT FOR TREATMENT AND PREVENTION OF VIRAL DISEASES.
    申请人:Beijing Molecule Science and Technology Co., Ltd.
    公开号:EP2048141B1
    公开(公告)日:2017-06-14
  • US8168642B2
    申请人:——
    公开号:US8168642B2
    公开(公告)日:2012-05-01
  • US8329902B2
    申请人:——
    公开号:US8329902B2
    公开(公告)日:2012-12-11
查看更多